Endovenous Laser Treatment, also known as endovenous laser ablation, is a non-surgical, outpatient laser treatment for varicose veins. It utilizes ultrasound-guided technology to precisely deliver laser energy that targets malfunctioning veins and causes them to collapse. Once closed, the blood flow is naturally redirected to healthier veins.
According to the new market research report “Varicose Vein Treatment Market in North America and Europe by Treatment Mode (Endovenous Ablation, Sclerotherapy, Stripping), Products (Laser & RF Ablation, Venous Closure, Surgical) - Forecasts to 2021", published by MarketsandMarkets™, The varicose vein treatment market in North America and Europe is expected to reach USD 289.7 Million by 2021 from USD 207.9 Million in 2016, at a CAGR of 6.9% between 2016 and 2021.Get 10% Free Customization on this report @https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=22524107The report provides a detailed overview of the major drivers, restraints, opportunities, and challenges impacting the varicose vein treatment market in North America and Europe along with the estimates and forecasts of the revenue and market share analysis.This report broadly segments the varicose vein treatment market into mode of treatment and products.
The varicose vein treatment market, by products is segmented into ablation devices, venous closure products, and surgical products.
The ablation devices segment is further categorized into radiofrequency ablation devices and laser ablation devices.
On the basis of mode of treatment, the varicose vein treatment market is segmented into endovenous ablation, injection sclerotherapy, and surgical ligation/stripping.Browse and in-depth TOC on “Varicose Vein Treatment Market”67 - Tables19 - Figures149 - PagesRequest Bundle Reports @https://www.marketsandmarkets.com/RequestBundleReport.asp?id=22524107Objectives of the study are:• To define, describe, and forecast the market in North America and Europe on the basis of mode of treatment, products, and regions• To provide detailed information regarding major factors influencing the growth of the market in North America and Europe (drivers, restraints, opportunities, and industry-specific challenges)• To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders• To strategically profile the key players and comprehensively analyze their market sharesFor Press release, visit:https://www.marketsandmarkets.com/PressReleases/varicose-vein-treatment.aspStakeholdersVaricose vein treatment product manufacturers, vendors, and distributorsResearch institutes and government organizationsVenture capitalists and other government funding organizationsResearch and consulting firmsHealthcare institutions (hospitals and medical schools)Pharmaceutical and biotechnology companies
According to the report, the global varicose vein treatment market was valued at ~US$ 1.5 Bn in 2018 and is projected to expand at a CAGR of ~5% from 2019 to 2027.Request Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=11714Varicose vein is one of the common diseases caused due to damage to the vein valves.
Endovenous ablation is a less-invasive treatment option for varicose veins.In terms of treatment type, the supportive treatments segment accounted for a major share of the global varicose vein treatment market in 2018.
Moreover, increase in awareness about ablation devices is expected to fuel the growth of the segment.
Based on end user, the hospitals & ambulatory surgical centers segment accounted for a major share of the market, due to the availability of services and rise in the rate of hospitalization.
Moreover, the preference for ambulatory surgical centers due to short hospital stays is likely fuel the growth of the segment.Request COVID Analysis on Varicose Vein Treatment Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=11714Global Varicose Vein Treatment Market: Prominent RegionsNorth America held a major share of the global varicose vein treatment market in 2018.
According to the American Heart Association, Inc., the prevalence of reticular vein and spider telangiectasias is higher in women in the U.S. Europe held the second-largest share of the global varicose vein treatment market in 2018.
